Domov › Metastatski rak › Arizona › Phoenix
Klinične študije za Metastatski rak v Phoenix, AZ
20 študij za Metastatski rak išče udeležence na lokacijah v Phoenix in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Vključevanje udeležencevFaza 3
- City of Hope, Phoenix
PRE-ISPY Phase I/II Oncology Platform Program
Vključevanje udeležencevFaza 1/2
- Mayo Clinic Comprehensive Cancer Center, Phoenix
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Vključevanje udeležencevFaza 2/3
- Mayo Clinic Hospital, Phoenix
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- Banner MD Anderson Cancer Center, Phoenix
- Ironwood Cancer & Research Centers, Phoenix
- Mayo Clinic Building- Phoenix, Phoenix
- in še 1
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Mayo Clinic Arizona, Phoenix
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- Mayo Clinic Building-Phoenix, Phoenix
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Vključevanje udeležencevFaza 2/3
- Mayo Clinic Hospital, Phoenix
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Ironwood Cancer & Research Centers, Phoenix
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Vključevanje udeležencevFaza 3
- HonorHealth, Phoenix
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- Mayo Clinic in Arizona - Phoenix, Phoenix
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Vključevanje udeležencevFaza 2
- Mayo Clinic Arizona, Phoenix
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Vključevanje udeležencevFaza 1/2
- Mayo Clinic Building- Phoenix, Phoenix
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Banner University Medical Center Phoenix, Phoenix
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Mayo Clinic, Phoenix
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Vključevanje udeležencevFaza 1/2
- Crinetics Study Site, Phoenix
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Investigative Site #132, Phoenix
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Vključevanje udeležencev
- Dignity Health, Phoenix
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Vključevanje udeležencevOpazovalna študija
- Mayo Clinic in Arizona, Phoenix
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Mayo Clinic, Phoenix
Študije za Metastatski rak v drugih mestih
- Houston, TX104 študij
- New York City, NY93 študij
- Nashville, TN70 študij
- Boston, MA63 študij
- Los Angeles, CA57 študij
- St. Louis, MO54 študij
- Arlington, VA53 študij
- Philadelphia, PA46 študij
- Chicago, IL45 študij
- San Antonio, TX44 študij
- Washington, DC43 študij
- Dallas, TX42 študij
Druge študije v Phoenix
- Rak dojke25 študij
- Kolorektalni rak25 študij
- Debelost22 študij
- Nemalicelični pljučni rak20 študij
- Srčno popuščanje18 študij
- Rak (vse vrste)17 študij
- Rak prostate17 študij
- Srčno-žilne bolezni16 študij
- Množni mielom16 študij
- Rak trebušne slinavke16 študij
- Prekomerna telesna teža15 študij
- Alzheimerjeva bolezen15 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.